Open
有鑑於感染病診斷技術(shù)上仍有臨床上的需求未被滿足,有許多感染病人,病程進(jìn)展快,感染原因不明,醫(yī)師因?yàn)槿狈Ω咝实脑\斷工具,而無(wú)法第一時(shí)間精準(zhǔn)地給予病人最正確的治療,常常因此錯(cuò)失了治療的黃金時(shí)間。 亞洲準(zhǔn)譯提供病原高通量基因定序檢驗(yàn)服務(wù),可以在一次檢驗(yàn)中,以病人的血液、腦脊液、組織、肺泡灌洗液等檢體進(jìn)行定序分析,透過(guò)與臨床病原資料庫(kù)中12,593種病原體(包括細(xì)菌、真菌、分枝桿菌、病毒、寄生蟲、披衣菌、立克次體)比對(duì)後,在2-3天內(nèi)提供醫(yī)師及時(shí)且正確的資訊協(xié)助醫(yī)師進(jìn)行診斷,以擬定最佳治療方案。 亞洲準(zhǔn)譯期許能成為專業(yè)醫(yī)療人員的最佳夥伴,透過(guò)提供全面、快速、精準(zhǔn)的檢驗(yàn)服務(wù),與醫(yī)療人員一起改善感染病人的醫(yī)療品質(zhì)。
a startup developed a metagenomic next-generation sequencing (mNGS) method which is a hypothesis free and timely method that could sequence every single pathogen, inclusive of bacteria, virus, fungus, and parasite, in one test
a startup developed a metagenomic next-generation sequencing (mNGS) method which is a hypothesis free and timely method that could sequence every single pathogen, inclusive of bacteria, virus, fungus, and parasite, in one test